8-K: UFP Technologies Expands MedTech Portfolio with Strategic Acquisitions of Welch Fluorocarbon and Marble Medical

UFP Technologies has acquired Welch Fluorocarbon and Marble Medical, enhancing its capabilities in thin film thermoforming and adhesive-based medical components.

Summary

• UFP Technologies has completed the acquisition of Welch Fluorocarbon for $34.6 million in cash, with a potential additional $6 million based on EBITDA targets.
• Welch Fluorocarbon, founded in 1985, specializes in thermoformed and heat-sealed implantable medical device components and had approximately $15 million in annual sales.
• The purchase price for Welch was approximately 11.5 times its adjusted EBITDA for the 12-month period ended December 31, 2023.
• UFP Technologies also acquired Marble Medical for $4.5 million in cash, with a potential additional $0.5 million based on sales targets.
• Marble Medical, founded in 1988, develops and manufactures adhesive-based medical components and single-use devices and had approximately $5 million in annual sales.
• The purchase price for Marble was approximately 4.5 times its adjusted EBITDA for the 12-month period ended December 31, 2023.
• Both acquisitions include customary representations, warranties, indemnities, and covenants, with a portion of the purchase price held in escrow for potential claims.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the strategic acquisitions, which are expected to enhance UFP's capabilities and growth prospects. The financial terms appear reasonable, and management commentary is optimistic.

Positives

• The acquisition of Welch Fluorocarbon expands UFP's capabilities in thin film thermoforming for implantable medical devices.
• The acquisition of Marble Medical enhances UFP's expertise in adhesive-based medical components and single-use devices.
• Both acquisitions are expected to provide synergies and growth opportunities for UFP Technologies.
• The acquisitions align with UFP's strategic focus on expanding its MedTech portfolio.
• Welch Fluorocarbon and Marble Medical are both considered a good cultural fit for UFP Technologies.
• Marble Medical is a 3M Preferred Converter, which provides access to a broader range of innovative solutions.

Risks

• There is a risk that UFP may not realize the anticipated benefits of the acquisitions due to integration challenges or other factors.
• The forward-looking statements in the press releases are subject to risks and uncertainties that could cause actual results to differ materially.
• The integration of the acquired companies may present challenges and require significant management attention.

Future Outlook

The company anticipates growth and synergies from the acquisitions, with a focus on expanding its MedTech portfolio and leveraging the acquired companies' technologies and expertise. The company also notes that forward-looking statements are subject to risks and uncertainties.

Management Comments

• R. Jeffrey Bailly, chairman and CEO of UFP Technologies, stated that Welch Fluorocarbon will bring significant thin film thermoforming capabilities to their expanding MedTech portfolio.
• R. Jeffrey Bailly, chairman and CEO of UFP Technologies, stated that Marble Medical's adhesives expertise is a great complement to their surgical robot drapes and stick to skin device platforms.
• Kevin Wiley, Owner and CEO of Welch Fluorocarbon, stated that they are thrilled to have selected UFP as their new home.
• Joe Audie, Marble Medical's president, stated that they are excited to join the UFP family and be part of such a fast growing and dynamic company.

Industry Context

The acquisitions reflect a trend of consolidation in the medical device manufacturing industry, where companies are seeking to expand their capabilities and market reach through strategic acquisitions. UFP Technologies is positioning itself as a key player in the MedTech supply chain by acquiring companies with complementary technologies and expertise.

Comparison to Industry Standards

• The EBITDA multiples paid for Welch (11.5x) and Marble (4.5x) are within the range of typical valuations for acquisitions in the medical device component manufacturing sector, but the Welch multiple is higher than the Marble multiple.
• Comparable companies in the medical device component manufacturing space include Integer Holdings Corporation and Nordson Corporation, which have also made acquisitions to expand their product offerings and market presence.
• The focus on thin film thermoforming and adhesive-based technologies aligns with the growing demand for advanced materials and components in the medical device industry.
• The acquisitions are expected to enhance UFP's competitive position by providing a broader range of solutions and vertical integration capabilities.

Stakeholder Impact

• Shareholders are expected to benefit from the enhanced growth prospects and synergies resulting from the acquisitions.
• Employees of Welch Fluorocarbon and Marble Medical are expected to become part of the UFP Technologies team.
• Customers of UFP Technologies will have access to a broader range of solutions and capabilities.
• Suppliers of UFP Technologies may see increased demand for their products and services.

Next Steps

• UFP Technologies will integrate Welch Fluorocarbon and Marble Medical into its existing operations.
• The company will focus on realizing synergies and growth opportunities from the acquisitions.
• UFP will continue to monitor the performance of the acquired companies and adjust its strategy as needed.

Key Dates

Keywords

Acquisition, MedTech, Medical Devices, Thermoforming, Adhesives, UFP Technologies, Welch Fluorocarbon, Marble Medical, Implantable Devices, Single-Use Devices